Carcinoid Tumors
September 2021 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Carcinoid Tumors abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Carcinoid Tumors. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Carcinoid Tumors. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Carcinoid Tumors every 3 months. Thank you for your ongoing subscription to this publication.

Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Successful endoscopic resection of an unusually enlarged and pedunculated type I gastric carcinoid tumour.
Authors:Odisho T, Shi D, Aburashed A
Institution:Department of Surgery, Detroit Medical Center, Detroit, Michigan, USA tanya.odisho@gmail.com.
Journal:BMJ Case Rep. 2021 Aug 19;14(8):e244292. doi: 10.1136/bcr-2021-244292.

2:Long-term survival and recurrence after resection of bronchopulmonary carcinoids: A single-center cohort study of 236 patients.
Authors:Soldath P, Binderup T, Kjær A, Federspiel B, Langer SW, Knigge U, Petersen RH
Institution:Department of Cardiothoracic Surgery, Rigshospitalet, Copenhagen, Denmark; ENETS Neuroendocrine Tumor Centre of Excellence Rigshospitalet, University of Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. Electronic address: Patrick.Soldath@regionh.dk. Department of Cardiothoracic Surgery, Rigshospitalet, Copenhagen, Denmark; ENETS Neuroendocrine Tumor Centre of Excellence Rigshospitalet, University of Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. Electronic address: Rene.Horsleben.Petersen@regionh.dk.
Journal:Lung Cancer. 2021 Jun;156:109-116. doi: 10.1016/j.lungcan.2021.04.010. Epub 2021 Apr 26.

3:Value of a patient-reported-outcome measure of carcinoid syndrome symptoms.
Authors:Maurel J, Guimbaud R, Lecomte T, Lièvre A, Hautefeuille V, Robinson P, Francois L, Lombard-Bohas C, Forestier J, Milot L, Subtil F, Walter T
Institution:Service d'Oncologie Médicale et Hépatogastroentérologie, Hospices Civil de Lyon, Lyon, France. France. Lyon, France. Lyon, France. Lyon, France.
Journal:Eur J Endocrinol. 2021 May;184(5):711-722. doi: 10.1530/EJE-20-1138.

4:Percutaneous Image-Guided Core Needle Biopsy of Neuroendocrine Tumors: How Common Is Intraprocedural Carcinoid Crisis?
Authors:Jang S, Schmitz JJ, Atwell TD, Welch TL, Welch BT, Hobday TJ, Adamo DA, Moynagh MR
Institution:Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905. Electronic address: jang.samuel@mayo.edu. 55905. 55905. Street SW, Rochester, Minnesota 55905. 55905. 55905. 55905. 55905.
Journal:J Vasc Interv Radiol. 2021 May;32(5):745-751. doi: 10.1016/j.jvir.2021.01.264. Epub 2021 Feb 16.

5:Examination of factors associated with lymph node metastases in lung carcinoids: Results from a single institution retrospective cohort study.
Authors:Pathipati MP, Yohannan TK, Tian L, Hornbacker K, Benson JA, Berry GJ, Lui NS, Kunz PL, Padda SK
Institution:Stanford University School of Medicine, Stanford Cancer Institute, Department of Medicine, Division of Oncology, 875 Blake Wilbur, Stanford, CA, 94305, USA; Massachusetts General Hospital, Division of Internal Medicine, 55 Fruit Street, Boston, MA, 02114, USA. Stanford University School of Medicine, Stanford Cancer Institute, Department of Medicine, Division of Oncology, 875 Blake Wilbur, Stanford, CA, 94305, USA. Electronic address: padda@stanford.edu.
Journal:Lung Cancer. 2021 Apr;154:186-194. doi: 10.1016/j.lungcan.2021.01.017. Epub 2021 Jan 23.

6:Risk factors for lymph node metastasis and survival of patients with nonampullary duodenal carcinoid tumors treated with endoscopic therapy versus surgical resection: analysis of the Surveillance, Epidemiology, and End Results program.
Authors:Wang R, Mohapatra S, Jovani M, Akshintala VS, Kamal A, Brewer OG, Kumbhari V, Shin EJ, Canto MI, Khashab MA, Singh VK, Lennon AM, Kalloo AN, Ngamruengphong S
Institution:Gastroenterology Department, West China Hospital of Sichuan University, Chengdu, Sichuan, China; Department of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, Maryland, USA.
Journal:Gastrointest Endosc. 2021 Jun;93(6):1384-1392. doi: 10.1016/j.gie.2020.12.012. Epub 2021 Feb 15.

7:Preoperative Biopsy Diagnosis in Pulmonary Carcinoids, a Shot in the Dark.
Authors:Moonen L, Derks JL, Hermans BCM, Bunnik IM, Hillen LM, van Suylen RJ, den Bakker MA, von der Thüsen JH, Damhuis RA, van den Broek EC, Buikhuisen WA, Dingemans AC, Speel EJM
Institution:Department of Pathology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. Electronic address: ernstjan.speel@mumc.nl.
Journal:J Thorac Oncol. 2021 Apr;16(4):610-618. doi: 10.1016/j.jtho.2020.12.004. Epub 2020 Dec 14.

8:The Role of Adjuvant Chemotherapy in Non-Metastatic Goblet Cell Carcinoid of the Appendix: An 11-Year Experience from the National Cancer Database.
Authors:AlMasri S, Nassour I, Kowalsky SJ, Hrebinko K, Singhi AD, Lee KK, Choudry HA, Bartlett D, Zureikat A, Paniccia A
Institution:Department of Surgery, Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, PA, USA. Pittsburgh, PA, USA. Pittsburgh, PA, USA. Pittsburgh, PA, USA. Pittsburgh, PA, USA. Pittsburgh, PA, USA. Pittsburgh, PA, USA. Pittsburgh, PA, USA. panicciaa2@upmc.edu.
Journal:Ann Surg Oncol. 2021 Jul;28(7):3873-3881. doi: 10.1245/s10434-020-09389-3. Epub 2020 Nov 24.

9:Diagnostic yield of the capsule endoscopy and enteroscopy combination for early small bowel carcinoid tumors.
Authors:Alventosa Mateu C, Luján Sanchis M, Boix Clemente C
Institution:Patología Digestiva, Consorcio Hospital General Universitario Valencia, España.
Journal:Rev Esp Enferm Dig. 2021 Apr;113(4):305. doi: 10.17235/reed.2020.7262/2020.

10:Features of carcinoid heart disease identified by cardiac computed tomography.
Authors:Davar J, Lazoura O, Caplin ME, Toumpanakis C
Institution:Carcinoid Heart Disease Clinic, Department of Cardiology, Royal Free Hospital, London, United Kingdom. Electronic address: j.davar@nhs.net. address: olgalazoura@nhs.net. United Kingdom. Electronic address: m.caplin@ucl.ac.uk. United Kingdom. Electronic address: c.toumpanakis@nhs.net.
Journal:J Cardiovasc Comput Tomogr. 2021 Mar-Apr;15(2):167-174. doi: 10.1016/j.jcct.2020.08.009. Epub 2020 Sep 6.

11:Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl: Analyses of Phase III Studies in Carcinoid Syndrome.
Authors:Dillon JS, Kulke MH, Hörsch D, Anthony LB, Warner RRP, Bergsland E, Welin S, O'Dorisio TM, Kunz PL, McKee C, Lapuerta P, Banks P, Pavel M
Institution:Department of Internal Medicine - Endocrinology and Metabolism, University of Iowa, Iowa City, IA, USA. joseph-dillon@uiowa.edu. Zentralklinik Bad Berka, Bad Berka, Germany. USA. USA. Iowa City, IA, USA. USA. Germany. Friedrich-Alexander-Universität, Erlangen-Nürnberg, Erlangen, Germany.
Journal:J Gastrointest Cancer. 2021 Mar;52(1):212-221. doi: 10.1007/s12029-020-00375-2.

For a FREE PREVIEW of the Medifocus Guidebook on Carcinoid Tumors click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Carcinoid Tumors click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Carcinoid Tumors...
at a Special 20% Discount


Medifocus Guidebook on Carcinoid Tumors

Updated: July 1, 2021
212 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Carcinoid Tumors is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

CT83945951

Coupon Expires: November 24, 2021



What Our Customers Are Saying...

"The MediFocus Guidebook on Carcinoid Tumors helped me prepare for my operation. It was reassuring to be able to communicate with my surgeon and the consulting doctors having knowledge about my condition."
P.T.
Newcastle, England


"The Guide is detailed and written in a way that the layman can readily understand. My wife, who has just had a Carcinoid Tumor removed, is reading it as I write this. It will be helpful in her recovery and ongoing therapy."
F.B.
Nanaimo, British Columbia


"The MediFocus Guidebook on Carcinoid Tumors was extremely informative and easy to understand. Now I'm able to discuss my condition with my doctor in an informed manner and make better decisions regarding my treatment."
J.P.F.
Agoura Hills, California



  
Medifocus Digest Alert is published by Medifocus, Inc.
3809 Clarks Lane, Suite 100, Baltimore, MD 21215 USA
Copyright © 2021 Medifocus, Inc. All rights reserved.